id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3239451,4ce76927-204f-448c-a300-059d2b1ba02d,Q3,"THE LIAISON GROUP, LLC",401104378,NATIONAL CANNABIS ROUNDTABLE,2024,third_quarter,CSP,"Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office",65500,,0,0,2024-10-16T09:35:23-04:00